13 is a novel NF-?B inhibitor that shows promising in-vitro effectiveness data Rabbit polyclonal to CD146 against pancreatic malignancy. 13-197 is definitely well distributed to the peripheral cells and has relatively high cells: plasma concentration ratios ranging from 1.8 to 3634 in both mice and rats. 13-197 also shown more than 99% binding to plasma… Continue reading 13 is a novel NF-?B inhibitor that shows promising in-vitro effectiveness